Migraine With Brainstem Aura Drugs Market to Reach USD 1.51 Billion by 2031 | Growth Insights Global Migraine With Brainstem Aura drugs market is entering a phase of sustained expansion as healthcare systems place greater emphasis on rare and complex neurological disorders. Valued at USD 0.82 billion in 2024, the market is projected to grow from USD 0.88 billion in 2025 to USD 1.51 billion by 2031, registering a compound annual growth rate (CAGR) of 7.8% over the forecast period. Rising diagnostic accuracy, expanding access to specialty care, and innovation in targeted migraine therapies are reshaping treatment paradigms worldwide. Access the market report https://www.24lifesciences.com/migraine-with-brainstem-aura-drugs-market-9082